Cell and gene therapy (CGT) has the potential to transform medicine, providing long-term and potentially curative treatment options for a wide range of diseases.
GenScript ProBio is dedicated to developing a robust adherent and suspension AAV production platform to support the development and manufacturing of flexible and high-quality lentiviral vectors.
Lentiviral vectors are a useful vehicle in delivering genes of interest (GOI) in cell and gene therapies, and therefore, the safety and stable manufacturing of LVV is drawing attention.